| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Diabetes type 2 | 8,582 | 268 | |
| Diabetes type 1 | 1,396 | 36 | |
| Cystic fibrosis-related diabetes | 11 | 3 | |
| General health | 9 | 3 | |
| Elevated blood sugar (hyperglycemia) | 7 | 1 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Low blood sugar (hypoglycemia) | 14 | |
| Weight gain | 11 | |
| Reactive hypoglycemia | 5 | |
| Nausea | 4 | |
| Burning pain at injection site | 3 | |
| Injection site pain | 3 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 3 | |
| Moderate | 21 | |
| Mild | 58 | |
| None | 223 |
Member evaluations
dresbaby
evaluated on Dec 05, 2009
- Perceived effectiveness for Diabetes Type II insulin dependent: Moderate
- Side effects: None
Ern
evaluated on Sep 01, 2009
- Perceived effectiveness for diabetes type 1: Moderate
- Side effects: None
Brenda8859
evaluated on Apr 23, 2009
- Perceived effectiveness for diabetes type 2: Major
- Side effects: None